CLINICAL_TRIALS
trial_result
· 2010-09-15
Clinical Trial Update: A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) [Phase 2]
Summary
Phase 2 dose-finding trial of MK0974 (telcagepant) for acute migraine completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2010-09-15